首页> 外文期刊>The journal of sexual medicine >Sexual dysfunction in women with clinical hypothyroidism and subclinical hypothyroidism.
【24h】

Sexual dysfunction in women with clinical hypothyroidism and subclinical hypothyroidism.

机译:临床甲状腺功能减退和亚临床甲状腺功能减退的女性的性功能障碍。

获取原文
获取原文并翻译 | 示例
           

摘要

INTRODUCTION: Hypothyroidism is a common hormonal disorder in women that may affect the phases of female sexual function. AIM: To investigate female sexual function in patients with clinic hypothyroidism and subclinic hypothyroidism. METHODS: A total of 25 women with clinic hypothyroidism (group 4), 25 women with subclinic hypothyroidism [thyroid stimulating hormone (TSH) value 10 mU/L (group 3)], and 20 age matched voluntary healthy women controls (group 1) were included in the study. All the subjects were evaluated with a detailed medical and sexual history, including a female sexual function index (FSFI) questionnaire for sexual status and the Beck Depression Inventory for psychiatric assessment. MAIN OUTCOME MEASURES: The levels of serum TSH, thyroid hormones, prolactin (PRL), free testosterone, estradiol, follicle-stimulating hormone, luteinizing hormone, lipid profile, and blood glucose were measured. RESULTS: Female sexual dysfunction (FSD) was diagnosed in 14 of 25 patients (56%) in group 4, in 6 of 11 patients (54.6%) in group 3, in 2 of 14 patients (14.6%) in group 2, and while only 3 of 20 the control group of women (15%) had FSD (P = 0.006). The mean total FSFI scores were 23.9 in the group 4, 26.03 in the group 3, 29.2 in the group 2, and 32.30 in the control group (P < 0.0001). The mean BDI score for clinic hypothyroidic patients was significantly greater than the scores for the control group and for the group 2 (P = 0.017 and P = 0.043, respectively). The mean PRL levels for patients in group 4 and group 3 were found to be significantly higher than the level for controls (P < 0.0001), whereas other serum hormone levels were not different among groups. CONCLUSIONS: A significant percent of women with clinic hypothyroidism and subclinic hypothyroidism with TSH values >10 mU/L had sexual dysfunction. Hyperprolactinemia, hyperlipidemia, and depression were associated with FSD in clinic hypothyroidism. Different than clinic hypothyroidism depression was not associated with FSD in subclinic hypothyroidism with TSH values >10 mU/L.
机译:简介:甲状腺功能减退症是女性常见的荷尔蒙紊乱,可能会影响女性性功能的各个阶段。目的:探讨临床甲状腺功能减退症和亚临床甲状腺功能减退症患者的女性性功能。方法:共有25例临床甲状腺功能减退的妇女(第4组),25例亚临床甲状腺功能减退的妇女[甲状腺刺激激素(TSH)值<或= 10 mU / L(第2组),TSH值> 10 mU / L(第3组) )],并纳入20位年龄相匹配的自愿健康女性对照(第1组)。对所有受试者进行了详细的医学和性病史评估,包括用于性状况的女性性功能指数(FSFI)调查表和用于精神病学评估的贝克抑郁量表。主要观察指标:测量血清TSH,甲状腺激素,催乳素(PRL),游离睾丸激素,雌二醇,促卵泡激素,促黄体生成激素,脂质分布和血糖水平。结果:在第4组的25名患者中有14名(56%)被诊断为女性性功能障碍(FSD),在第3组的11名患者中有6名(54.6%)被诊断为女性,第2组的14名患者中有2名(14.6%)被诊断为女性。而20名中只有3名对照组女性(15%)患有FSD(P = 0.006)。第4组的平均FSFI总得分为23.9,第3组为26.03,第2组为29.2,对照组为32.30(P <0.0001)。临床甲状腺功能减退患者的平均BDI评分显着高于对照组和第2组的评分(分别为P = 0.017和P = 0.043)。发现第4组和第3组患者的平均PRL水平显着高于对照组(P <0.0001),而其他血清激素水平在各组之间没有差异。结论:临床甲状腺功能减退和亚临床甲状腺功能减退的TSH值> 10 mU / L的女性中,有很大一部分患有性功能障碍。高催乳素血症,高脂血症和抑郁症与临床甲状腺功能减退症中的FSD有关。与亚临床甲状腺功能减退症不同的是,亚临床甲状腺功能减退症中TSH值> 10 mU / L与抑郁症无关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号